A drug that can ease the process of quitting smoking by reducing the craving for cigarettes will be available to participants in a Yale study. The study will try to determine what kind of information works best when it comes to encouraging smokers to...
In light of current world events, Yale School of Nursing (YSN) will host a public forum to address how religious diversity and tolerance affect health care in our community on April 24, at 5:30 p.m. in room 118, YSN, 100 Church St. South. David Shaheed...
A study by Yale University researchers provides preliminary evidence that there may be more than twice as many genes in the human genome than previously predicted. Using an advanced genomic technique, researchers looked for all the genes on human...
A study by Yale researchers suggests that the atypical antipsychotic drug risperidone reduces tic symptoms in children and adults with Tourette syndrome (TS). “These results suggest that risperidone is safe and effective for short-term treatment of tics...
Charles Alderson Janeway, Jr., M.D., professor of immunobiology at the Yale University School of Medicine and a Howard Hughes Medical Institute investigator died on April 12 at age 60 in New Haven after a long illness. Janeway was one of the leading...
A molecule that destroys blood vessels in tumors also is effective against blood vessels associated with macular degeneration, the leading cause of blindness after age 55, according to a collaborative study by scientists at Yale University and the...
When “rogue” proteins begin wreaking havoc within cells, the result is diseases such as cancer, heart disease, and inflammatory diseases like rheumatoid arthritis. Scientists at Yale University and the Howard Hughes Medical Institute at California...
A new study of low-carbohydrate diets published in this week’s Journal of the American Medical Association shows that carbohydrate content in a person’s diet is not associated with weight loss. “We found that calorie content and how long you’re on the...
The Yale School of Medicine’s Department of Psychiatry is offering 12 weeks of free cognitive behavioral therapy for major depression as part of a study to measure possible changes in brain chemistry associated with treatment. The neurotransmitter GABA...
The National Alliance for Research on Schizophrenia and Depression (NARSAD) has awarded 13 grants totaling close to $780,000 to Yale School of Medicine psychiatric researchers. Yale received the second largest number of awards this year out of all...